Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients

Reuters

2025/10/22

Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients

Heartflow Inc. has announced new developments in clinical research and product offerings related to coronary intervention planning. The company's PLAN CALCIUM study evaluated the impact of integrating Heartflow Plaque Analysis with coronary CTA imaging and FFRCT analysis to inform interventional cardiologists' decisions on percutaneous coronary intervention $(PCI)$ in patients with highly calcified lesions. Data from the PLAN CALCIUM study will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference, scheduled for October 26, 2025. Additionally, Heartflow will initiate the NAVIGATE-PCI Registry in 2026, enrolling approximately 2,500 patients across 30 U.S. sites. This registry will assess the effect of the company's PCI Navigator tool on physician confidence, procedural safety, efficiency, strategy, and patient outcomes compared to standard care. Heartflow will also demonstrate PCI Navigator at their exhibit booth during the TCT 2025 conference.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9549915-en) on October 22, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2577369770"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2577369770\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2577369770?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-22 20:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577369770","market":"nz","top_or_hot":-1,"title":"Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Heartflow Inc. has announced new developments in clinical research and product offerings related to coronary intervention planning. The company's PLAN CALCIUM study evaluated the impact of integrating Heartflow Plaque Analysis with coronary CTA imaging and FFRCT analysis to inform interventional cardiologists' decisions on percutaneous coronary intervention <a href=\"https://laohu8.com/S/PCI\">$(PCI)$</a> in patients with highly calcified lesions. Data from the PLAN CALCIUM study will be presented at the Transcatheter Cardiovascular <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (TCT) 2025 conference, scheduled for October 26, 2025. Additionally, Heartflow will initiate the NAVIGATE-PCI Registry in 2026, enrolling approximately 2,500 patients across 30 U.S. sites. This registry will assess the effect of the company's PCI Navigator tool on physician confidence, procedural safety, efficiency, strategy, and patient outcomes compared to standard care. Heartflow will also demonstrate PCI Navigator at their exhibit booth during the TCT 2025 conference.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9549915-en) on October 22, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHeartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-22 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Heartflow Inc. has announced new developments in clinical research and product offerings related to coronary intervention planning. The company's PLAN CALCIUM study evaluated the impact of integrating Heartflow Plaque Analysis with coronary CTA imaging and FFRCT analysis to inform interventional cardiologists' decisions on percutaneous coronary intervention <a href=\"https://laohu8.com/S/PCI\">$(PCI)$</a> in patients with highly calcified lesions. Data from the PLAN CALCIUM study will be presented at the Transcatheter Cardiovascular <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (TCT) 2025 conference, scheduled for October 26, 2025. Additionally, Heartflow will initiate the NAVIGATE-PCI Registry in 2026, enrolling approximately 2,500 patients across 30 U.S. sites. This registry will assess the effect of the company's PCI Navigator tool on physician confidence, procedural safety, efficiency, strategy, and patient outcomes compared to standard care. Heartflow will also demonstrate PCI Navigator at their exhibit booth during the TCT 2025 conference.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9549915-en) on October 22, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4112","symbol_name":"金融交易所和数据","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nNDL2bghhM:1","article_id":"2577369770","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577369770","pubTimestamp":1761134441,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Heartflow Inc. has announced new developments in clinical research and product offerings related to coronary intervention planning. The company's PLAN CALCIUM study evaluated the impact of integrating Heartflow Plaque Analysis with coronary CTA imaging and FFRCT analysis to inform interventional cardiologists' decisions on percutaneous coronary intervention  in patients with highly calcified lesions. Data from the PLAN CALCIUM study will be presented at the Transcatheter Cardiovascular Therapeutics  2025 conference, scheduled for October 26, 2025. Additionally, Heartflow will initiate the NAVIGATE-PCI Registry in 2026, enrolling approximately 2,500 patients across 30 U.S. sites. This registry will assess the effect of the company's PCI Navigator tool on physician confidence, procedural safety, efficiency, strategy, and patient outcomes compared to standard care. Heartflow will also demonstrate PCI Navigator at their exhibit booth during the TCT 2025 conference.Disclaimer: This news bri","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4112":"金融交易所和数据","BK4585":"ETF&股票定投概念","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","HTFL":"HeartFlow Inc","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","BK4167":"医疗保健技术","NDAQ":"纳斯达克OMX交易所","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","BK4588":"碎股"},"translate_title":"Heartflow推出NAVIGATE-PCI注册，评估2,500名患者的人工智能引导PCI计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HTFL":0.9,"NDAQ":0.9},"content_text":"Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients\n    \n\n        Heartflow Inc. has announced new developments in clinical research and product offerings related to coronary intervention planning. The company's PLAN CALCIUM study evaluated the impact of integrating Heartflow Plaque Analysis with coronary CTA imaging and FFRCT analysis to inform interventional cardiologists' decisions on percutaneous coronary intervention $(PCI)$ in patients with highly calcified lesions. Data from the PLAN CALCIUM study will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference, scheduled for October 26, 2025. Additionally, Heartflow will initiate the NAVIGATE-PCI Registry in 2026, enrolling approximately 2,500 patients across 30 U.S. sites. This registry will assess the effect of the company's PCI Navigator tool on physician confidence, procedural safety, efficiency, strategy, and patient outcomes compared to standard care. Heartflow will also demonstrate PCI Navigator at their exhibit booth during the TCT 2025 conference.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9549915-en) on October 22, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}